Benefits of early use of high-flow-nasal-cannula (HFNC) in patients with COVID-19 associated pneumonia.

Med Clin (Engl Ed) · 2022 · PMC9130639 · PMID 35634247

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

did not reach statistical significancep = 0.061so close (0.05 < p ≤ 0.1)

Finally, although the decrease in mortality did not reach statistical significance, there was a very-close-to-significance trend (p = 0.061), with a considerable reduction in mortality (22.7 vs. 55.5%), which makes it clinically relevant.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.